 | | |
| |
| | ANDO KIYOHIRO Last updated: Jul 11, 2019 at 15:04 | Name | ANDO KIYOHIRO |
|---|
Research funding number | 10455389 |
|---|
|
Academic & Professional Experience Assistant Professor, Nihon University School of Medicine, Department of Medicine Aug 2017 Assistant Professor, Div.of Biochemistry, Dpt. of Biomedical Science, Nihon University School of Medicine Education Apr 1992 - Mar 1998 医学科, 医学部, Nihon University Apr 2000 - Mar 2004 Nihon University Published Papers An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues. Molecular Oncology 11(10) 1448-1458 Jul 2017 [Refereed] NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus. The Journal of Cell Biology 216(6) 1795-1810 Jun 2017 [Refereed] An Inhibitor of PIDDosome Formation. Molecular cell 58(5) 767-779 Jun 2015 [Refereed] RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma. Yu F, Gao W, Yokochi T, Suenaga Y, Ando K, Ohira M, Nakamura Y, Nakagawara A. Oncogene 33(20) 2601-2609 May 2014 [Refereed] Ando K, Ozaki T, Hirota T, Nakagawara A PLos One Dec 2013 [Refereed] Conference Activities & Talks Possible therapeutic usage of checkpoint abrogation strategy for neuroblastoma treatment Kiyohiro Ando 第60回日本小児血液・がん学会学術総会 14 Nov 2018 The blockade of DNA damage response increase the sensitivity of CHK1 inhibitor in neuroblastoma 第77回日本癌学会学術総会 29 Sep 2018 checkpoint abrogationを応用した神経芽腫治療の可能性 Kiyohiro Ando 第27回日本癌病態治療研究会 31 May 2018 Research Grants & Projects CHK1阻害剤の細胞死誘導の分子機構に着目した感受性遺伝子の同定と臨床応用 Project Year: Apr 2018 - Mar 2021 Identifying predicators for therapeutic effect of CHK1 inhibitor in neuroblastoma Project Year: Apr 2018 - Mar 2019 |
|
|
|
| |
